β-Amyloid precursor protein (APP) and APP-RNA are rapidly affected by glutamate in cultured neurons - Selective increase of mRNAs encoding a kunitz protease inhibitor domain

Journal of Molecular Neuroscience

Volumn 6, Issue 4, 1995, Pages 257-276

  Willoughby, David A ^a   Rozovsky, Irina ^a   Lo, Amy C Y ^b   Finch, Caleb E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Alternative splicing; aminophosphonovalerate; APLP2; cortex; GLUR B; glutamate; neurodegeneration; NMDA receptor; rat

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APLP1 PROTEIN, HUMAN; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GLUTAMIC ACID; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RADIOACTIVE IODINE; TRYPSIN;

ANIMAL; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL DEATH; CHEMISTRY; CYTOLOGY; DOG; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; ISOMERISM; KIDNEY DISTAL TUBULE; METABOLISM; NERVE CELL; NERVE DEGENERATION; PHYSIOLOGY; RAT; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLUTAMIC ACID; IODINE RADIOISOTOPES; ISOMERISM; KIDNEY TUBULES, DISTAL; NERVE DEGENERATION; NEURONS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; TRANSFECTION; TRYPSIN;

EID: 0029421109     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/BF02736785     Document Type: Article

References (74)

1. Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor mRNA after persistent focal ischemia in rat cerebral cortex
2. Tyrosine hydroxylase mRNA expression by dopaminergic neurons in culture: effect of 1-methyl-4-pyridinium treatment
3. The Alzheimer’s amyloid precursor protein is produced by type I astrocytes in primary cultures of rat neuroglia
4. Reversible oxidation of glyceraldehyde 3-phosphate dehydrogenase thiols in human lung carcinoma cells by hydrogen peroxide
5. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
6. Ketamine, phenycyclidine, and MK-801 protect against kainic acid-induced seizure related brain damage
7. Cellular localization and laminar distribution of NMDAR1 mRNA in the rat cerebral cortex
8. Antibody to beta-amyloid precursor protein recognizes an intermediate filament-associated protein in Alzheimer’s and control fibroblasts
9. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro-3a, 6a-diphenylglycouril
10. Thrombin active site regions required for fibroblast receptor binding and initiation of cell division
11. Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
12. Expression of β amyloid protein protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer’s disease using PCR
13. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against β-peptide-induced oxidative injury
14. Transgenic mice expressing human beta-APP751, but not mice expressing beta-APP695, display early Alzheimer’s disease-like histopathology
15. Increased expression of β-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage
16. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer’s disease
17. Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks β/A4 amyloid immunoreactivity
18. The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell surface receptor
19. The sequence of two extra exons in rat pre-A4
20. Differential splicing of Alzheimer’s disease amyloid A4 precursor RNA in rat tissues: preA4 695 mRNA is predominately produced in rat and human brain
21. A family of AMPA-selective glutamate receptors
22. Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity
23. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay
24. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation
25. Differential APP gene expression in rat cerebral cortex, meninges, and primary astroglial, microglial, and neuronal cultures
26. Metabolism of the amyloid precursor-like protein 2 in MDCK cells
27. Glutamate neurotoxicity in cortical cell culture
28. β-amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer’s disease
29. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein
30. The role of glutamate in epilepsy and other CNS disorders
31. Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein
32. Molecular diversity of glutamate receptors and implications for brain function
33. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain
34. Amino acid sequence RERMS represents the active domain of amyloid beta/A4 protein precursor that promotes fibroblast growth
35. NMDA antagonist neurotoxicity: mechanism and prevention
36. Increased β-amyloid precursor protein expression in astrocytes in the gerbil hippocampus following ischaemia: association with proliferation of astrocytes
37. The glutamate antagonist MK-801 reduces focal brain damage in the rat
38. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors
39. Formation of β-amyloid protein deposits in brains of transgenic mice
40. Decrease in amyloid precursor protein precedes hippocampal degeneration in rat brain following transient global ischemia
41. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer’s disease
42. Torwards an improved serum-free chemically defined medium for long-term culturing of cerebral cortex tissue
43. Selective expression of clusterin (SGP2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro
44. Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts
45. βA4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons
46. Similar alternative splicing of a non-homologous domain in βA4-amyloid protein precursor-like proteins
47. Protease nexin-2/amyloid β protein precursor: a tight-binding inhibitor of coagulation factor IXa
48. Normal and abnormal biology of the β-amyloid precursor protein
49. Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1α immunoreactivity
50. Alzheimer’s disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact
51. Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage
52. Proteolytic processing of β-amyloid precursor by calpain I
53. Evidence that beta amyloid protein in Alzheimer’s disease is not derived by normal processing
54. Identification and transport of full length amyloid precursor proteins in rat peripheral nervous system
55. Secreted forms of β-amyloid precursor protein protect against ischemic brain injury
56. Increased levels of the Kunitz protease inhibitor-containing βAPP mRNAs in rat brain following neurotoxic damage
57. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS
58. Molecular cloning of the cDNA for a human amyloid precursor protein homolog: evidence for a multigene family
59. Tissue-specific expression of three types of β-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer’s disease brain
60. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease
61. Cellular specificity and regional distribution of amyloid β protein precursor alternative transcripts are unaltered in Alzheimer hippocampal formation
62. Amyloid precursor-like protein 2 (APLP2) is modified by the addition of chondronitin sulfate glycosaminoglycan at a single site
63. Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta protein precursor
64. The predominant form of the amyloid β-protein precursor in brain is protease nexin 2
65. Expression, purification, and characterization of the Kunitz-type proteinase inhibitor domain of the amyloid beta-protein precursor-like protein-2
66. Paradoxical potentiation by low extracellular Ca2+ of acute chemical neuronal injury in cerebellar granule cell culture
67. Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats
68. Isolation and characterization of APLP2 encoding a homologue of the Alzheimer’s associated amyloid β protein precursor
69. Identification, biogenesis, and localization of precursors of Alzheimer’s disease A4 amyloid protein
70. Amyloid precursor protein mRNA encoding the Kunitz protease inhibitor domain is increased by kainic acid-induced seizures in rat hippocampus
71. Lactate dehydrogenase activity in blood
72. Neuron-specific splicing of the Alzheimer amyloid precursor protein gene in a mini-gene system
73. Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3′-untranslated region